| Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ... The Lancet 401 (10388), 1584-1594, 2023 | 82 | 2023 |
| Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial BH Rovin, J Barratt, HJL Heerspink, CE Alpers, S Bieler, DW Chae, ... The Lancet 402 (10417), 2077-2090, 2023 | 36 | 2023 |
| Obesity and chronic kidney disease: a current review S Nawaz, R Chinnadurai, S Al‐Chalabi, P Evans, PA Kalra, AA Syed, ... Obesity Science & Practice 9 (2), 61-74, 2023 | 27 | 2023 |
| Community-versus hospital-acquired acute kidney injury in hospitalised COVID-19 patients JS Bell, BD James, S Al-Chalabi, L Sykes, PA Kalra, D Green BMC nephrology 22, 1-11, 2021 | 24 | 2021 |
| Managing acute presentations of atheromatous renal artery stenosis Á De Bhailis, S Al-Chalabi, R Hagemann, S Ibrahim, A Hudson, E Lake, ... BMC nephrology 23 (1), 210, 2022 | 3 | 2022 |
| Is it time to relax nephrogenic systemic fibrosis guidelines and safely offer magnetic resonance imaging to more patients? S Al-Chalabi, C Chrysochou, PA Kalra Quantitative Imaging in Medicine and Surgery 9 (11), 1918, 2019 | 3 | 2019 |
| Mechanistic links between central obesity and cardiorenal metabolic diseases S Al-Chalabi, AA Syed, PA Kalra, S Sinha Cardiorenal medicine 14 (1), 12-22, 2024 | 2 | 2024 |
| Etanercept-induced anti-glomerular basement membrane disease S Al-Chalabi, HHL Wu, R Chinnadurai, A Ponnusamy Case reports in nephrology and dialysis 11 (3), 292-300, 2022 | 2 | 2022 |
| Improving outpatient clinic experience: the future of chronic kidney disease care and associated multimorbidity S Al-Chalabi, H Alderson, N Garratt, D Green, PA Kalra, J Ritchie, ... BMJ Open Quality 12 (3), e002188, 2023 | 1 | 2023 |
| Association of deprivation and its individual domains on outcomes in people with chronic kidney disease S Al-Chalabi, E Parkinson, R Chinnadurai, PA Kalra, S Sinha Clinical Kidney Journal, sfae086, 2024 | | 2024 |
| Mortality and renal outcomes are impacted by obesity in cardiorenal metabolic disease but not in people with concomitant diabetes mellitus S Al-Chalabi, R Chinnadurai, PA Kalra, S Sinha Cardiorenal medicine 14 (1), 23-33, 2023 | | 2023 |
| Revolutionising outpatient clinic experience (RevOCE): the future of chronic kidney disease care and associated multimorbidity S Al-Chalabi, S Santhirasekaran, PA Kalra, J Ritchie, D Poulikakos, ... Future Healthcare Journal 10 (Suppl 3), 13, 2023 | | 2023 |
| Risk factors for infective endocarditis in patients receiving hemodialysis: A propensity score matched cohort study. S Al-Chalabi, T Tay, R Chinnadurai, PA Kalra Clinical Nephrology, 2023 | | 2023 |
| # 3559 THE IMPACT OF OBESITY ON CLINICAL OUTCOMES IN VARIOUS LEVELS OF CO-MORBIDITY OF NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS S Al-Chalabi, R Chinnadurai, PA Kalra, S Sinha Nephrology Dialysis Transplantation 38 (Supplement_1), gfad063c_3559, 2023 | | 2023 |
| An Eye to the Future: Development of a Metabolic-Renal-Cardiac (MRC) Service: PUB256 S Al-Chalabi, S Nawaz, H Alderson, PA Kalra, DJ Poulikakos, J Ritchie, ... Journal of the American Society of Nephrology 33 (11S), 953, 2022 | | 2022 |
| Risk of ESKD and Incidence of New-Onset Major Adverse Cardiovascular Events in a Large, Deprived Population With Type 2 Diabetes Mellitus: PUB101 S Al-Chalabi, S Santhirasekaran, S Sinha, PA Kalra, J Ritchie Journal of the American Society of Nephrology 33 (11S), 912, 2022 | | 2022 |
| Impact of body mass index on mortality and end-stage kidney disease in patients with non-dialysis dependent chronic kidney disease S Al-Chalabi, S Nawaz, M Lodge, S Sinha, PA Kalra, R Chinnadurai Nephrology Dialysis Transplantation 37, I296-I297, 2022 | | 2022 |
| MO412: Impact of Body Mass Index on Mortality and End–Stage Kidney Disease in Patients With Non-Dialysis Dependent Chronic Kidney Disease S Al-Chalabi, S Nawaz, M Lodge, S Sinha, P A. Kalra, R Chinnadurai Nephrology Dialysis Transplantation 37 (Supplement_3), gfac070. 026, 2022 | | 2022 |
| RISK FACTORS FOR INFECTIVE ENDOCARDITIS IN PATIENTS RECEIVING HAEMODIALYSIS-A PROPENSITY MATCHED COHORT STUDY S Al-Chalabi, T Tay, R Chinnadurai, PA Kalra NEPHROLOGY DIALYSIS TRANSPLANTATION 36, 416-416, 2021 | | 2021 |
| MO733 RISK FACTORS FOR INFECTIVE ENDOCARDITIS IN PATIENTS RECEIVING HAEMODIALYSIS-A PROPENSITY MATCHED COHORT STUDY S Al-Chalabi, T Tay, R Chinnadurai, PA Kalra Nephrology Dialysis Transplantation 36 (Supplement_1), gfab097. 0013, 2021 | | 2021 |
Philip KalraProfessor of Nephrology, Salford Royal and University of ManchesterVerified email at manchester.ac.uk
